TOKYO, April 13 (Reuters) - Japanese drug maker Eisai Co. Ltd. (4523.T: Quote, NEWS , Research) said on Friday it had tentatively withdrawn its European application for its Alzheimer’s drug Aricept to be also used to treat severe forms of the disease.
